A comparison between the COVID-19 and non-COVID-19 groups at the same time point revealed that the non-COVID-19 group exhibited significantly higher CD4+ T cell responses to the S, S1, and NMO antigens 4 weeks after the second booster. The gene discussed is CD4; the disease is neuromyelitis optica.